hexachlorobutadiene - Davidborowski.com

More documents

Recommendations

Info

HEXACHLOROBUTADIENE 16 2.2.1.7 Genotoxic Effects 2. HEALTH EFFECTS No studies were located regarding genotoxic effects in humans after inhalation exposure to hexachlorobutadiene. Hexachlorobutadiene did not cause dominant lethal mutations in rats after inhalation of vapors at concentrations of 10 or 50 ppm for up to 5 days (NIOSH 1981). Similarly, there were no increases in the frequency of chromosomal aberrations in bone marrow cells of rats exposed to 10 ppm for up to 5 days (NIOSH 1981). Other genotoxicity studies are discussed in Section 2.4. 2.2.1.8 Cancer No studies were located regarding cancer in humans or animals after inhalation exposure to hexachlorobutadiene. However, EPA has derived an inhalation unit risk of 0.022 (mg/m 3 ) -1 (IRIS 1993), based on oral exposure data (see Section 2.2.2.8). Exposure levels corresponding to excess cancer risks of 10 -4 to 10 -7 are shown in Figure 2-l. 2.2.2 Oral Exposure 2.2.2.1 Death No studies were located regarding death in humans after oral exposure to hexachlorobutadiene. Acute oral exposures to hexachlorobutadiene were lethal in rats. Young rats were more sensitive to compound exposure than adult rats. LD50 values for adult rats were 580 mg/kg (males) and 200-400 mg/kg (females). The LD50 values for weanling male and female rats were 65 and 46 mg/kg, respectively (Kociba et al. 1977a). Important experimental details of this study were not available for review. Mice exposed to 1,000 and 3,000 ppm hexachlorobutadiene in their diet (19-36 mg/kg/day) died after 3-5 days (NTP 1991; Yang et al. 1989). Animals exposed to 30-300 ppm (3-49 mg/kg/day)
HEXACHLOROBUTADIENE 17 2. HEALTH EFFECTS survived the 15 day exposure period. Survival was not reduced in rats exposed to 100 mg/kg/day hexachlorobutadiene for 30 days or at dose levels of 15.6 mg/kg/day for 13 weeks (Harleman and Seinen 1979) and 100 mg/kg/day (Kociba et al. 1971). Mice survived dose levels of up to 19.2 mg/kg/day for 13 weeks (NTP 1991). In lifetime studies, survival was reduced significantly in male rats exposed to hexachlorobutadiene at a dose level of 20 mg/kg/day (Kociba et al. 1977a). Although the cause of death was not reported, renal damage, a major effect manifested by this compound, may have been a contributing factor. A LOAEL value for lethality in rats after chronic exposure is recorded in Table 2-2 and plotted in Figure 2-2. 2.2.2.2. Systemic Effects No studies were located regarding respiratory, cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, or dermal/ocular effects in humans after oral exposure to hexachlorobutadiene for any duration category. Studies have been conducted in animals to evaluate the respiratory, cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, and renal effects. These effects are discussed below. No studies were located on dermal/ocular effects. The highest NOAEL values and all LOAEL values from each reliable study for systemic effects in each species and duration category are recorded in Table 2-2 and plotted in Figure 2-2. Respiratory Effects. Intermediate-duration (30-148 days) exposure to 20 mg/kg/day (Schwetz et al. 1977) or 100 mg/kg/day (Kociba et al. 1971) and lifetime exposures to 20 mg/kg/day (Kociba et al. 1977a) did not cause treatment-related lesions of the lungs or changes in lung weight in rats exposed to hexachlorobutadiene at dose levels of 20 mg/kg/day. Cardiovascular Effects. Hexachlorobutadiene did not alter heart weights or cause treatment-related lesions of the heart in rats or mice exposed for intermediate durations (90-148 days) at dose levels of 19.2-20 mg/kg/day (NTP 1991; Schwetz et al. 1977; Yang et al. 1989) and 100 mg/kg/day (Kociba et al. 1971) or after lifetime exposure at dose levels of 20 mg/kg/day (Kociba et al. 1977a).
Page 1 and 2: TOXICOLOGICAL PROFILE FOR HEXACHLOR
Page 3: HEXACHLOROBUTADIENE iii UPDATE STAT
Page 20 and 21: HEXACHLOROBUTADIENE 2 1.1 WHAT IS H
Page 22 and 23: HEXACHLOROBUTADIENE 4 1. PUBLIC HEA
Page 24 and 25: HEXACHLOROBUTADIENE 6 1. PUBLIC HEA
Page 27 and 28: HEXACHLOROBUTADIENE 9 2.1 INTRODUCT
Page 29 and 30: HEXACHLOROBUTADIENE 11 2. HEALTH EF
Page 31 and 32: FIGURE 2-1 Levels of Significant Ex
Page 33: HEXACHLOROBUTADIENE 15 2. HEALTH EF
Page 37 and 38: 4 Rat (F) 10-18 wk Renal 5 6 TABLE
Page 39 and 40: Reproductive 15 Rat 16 Rat 17 Mouse
Page 41 and 42: FIGURE 2-2 Levels of Significant Ex
Page 43 and 44: E psure to Hexachlorobutadiene - ra
Page 51 and 52: Species ACUTE EXPOSURE Death System
Page 53 and 54: HEXACHLOROBUTADIENE 35 2.2.3.8 Canc
Page 55 and 56: HEXACHLOROBUTADIENE 37 2.3.2 Distri
Page 81: HEXACHLOROBUTADIENE 63 2.9 ADEQUACY
Page 84 and 85:
HEXACHLOROBUTADIENE 66 2. HEALTH EF
Page 86 and 87:
HEXACHLOROBUTADIENE 68 2. HEALTH EF
Page 88 and 89:
HEXACHLOROBUTADIENE 70 2.9.3 On-goi
Page 93:
HEXACHLOROBUTADIENE 75 4.1 PRODUCTI
Page 97 and 98:
HEXACHLOROBUTADIENE 79 5.1 OVERVIEW
Page 101 and 102:
HEXACHLOROBUTADIENE 83 5.2.2 Water
Page 103 and 104:
HEXACHLOROBUTADIENE 85 5. POTENTIAL
Page 105 and 106:
HEXACHLOROBUTADIENE 87 5.4.3 Sedime
Page 107 and 108:
HEXACHLOROBUTADIENE 89 5.7.1 Identi
Page 109:
HEXACHLOROBUTADIENE 91 5. POTENTIAL
Page 112:
HEXACHLOROBUTADIENE 94 6. ANALYTICA
Page 117 and 118:
HEXACHLOROBUTADIENE 99 6. ANALYTICA
Page 119:
HEXACHLOROBUTADIENE 101 7. REGULATI
Page 124 and 125:
HEXACHLOROBUTADIENE 106 8. REFERENC
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
HEXACHLOROBUTADIENE 130 9. GLOSSARY
Page 150 and 151:
HEXACHLOROBUTADIENE 132 9. GLOSSARY
Page 152 and 153:
HEXACHLOROBUTADIENE A-l Chapter 1 P
Page 156 and 157:
HEXACHLOROBUTADIENE A-5 APPENDIX A
show all

hexachlorobutadiene - Davidborowski.com

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?